Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...
In this phase 3, open-label, randomized trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer who had received one previous line ...
School of Materials and Energy, International Joint Research Center for Advanced Energy Materials of Yunnan Province, Yunnan University, Kunming 650091, China ...
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...
State Key Laboratory of Medicinal Chemical Biology, The Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Science, Nankai University, Tianjin 300350, China ...
In this release, the alarm graphics have been updated to reflect what the real clocks' alarm graphics look like MUCH more closely, and new alarm sounds have been added. Documentation for the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback